Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario

Q4 Medicine
Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez
{"title":"Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario","authors":"Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez","doi":"10.24245/gom.v88i2.3427","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.","PeriodicalId":12654,"journal":{"name":"Ginecologia y obstetricia de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ginecologia y obstetricia de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/gom.v88i2.3427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.
遗传性乳腺癌和卵巢癌患者基因突变的发生率
目的:确定遗传型癌症的基因突变,并证明墨西哥人群中最常见的乳腺癌与患乳腺癌的风险之间是否存在显著关联。材料和方法:在墨西哥洛杉矶医院与国家基因组医学研究所合作进行的跨节和观察性研究。纳入标准:乳腺癌症患者和一个或多个受该疾病影响的一级亲属以及癌症患者。排除标准:无乳腺癌或卵巢癌癌症病史的患者,或方案中有家庭成员的患者。Master Mix Quantinova探针PCR试剂盒采用RT2 Profiler平板重排技术。采用SPSS第22版程序和Epi-Info第7版程序进行统计分析。结果:39例患者的平均年龄为53.2±12.1岁。促孕甾酮和雌激素受体在各组之间没有差异。有统计学差异,结论:获得的数据表明,在墨西哥人群中,BRCA2在遗传性癌症中的发病率更高,发病年龄更早,诊断时核分级更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ginecologia y obstetricia de Mexico
Ginecologia y obstetricia de Mexico Medicine-Obstetrics and Gynecology
CiteScore
0.20
自引率
0.00%
发文量
107
期刊介绍: Indizada en: Artemisa, Embase Cd/Obstetrics and Gynecology, Embase. Co/Pediatrics, Excerfta Médica, Índice Médico Latinoamericano, Lulacs, Medline, Science Citation Index, Ulrich, Ebsco.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信